Michael Makanga - Concepedia

Author

Michael Makanga

European & Developing Countries Clinical Trials Partnership ORCID

Also Known As

M Makanga, M. Makanga, MICHAEL MAKANGA, Makanga, Michael, Michael M. Makanga, Michael Makanga, Syed Aajmain

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

European & Developing Countries Clinical Trials Partnership Kenya Medical Research Institute Novartis (Switzerland)University College London Medicines for Malaria Venture

About

Michael Makanga is an author at European & Developing Countries Clinical Trials Partnership specializing in medicine, malaria, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	311
2	Health Sciences	1	1	82
3	Natural Sciences	1	1	13
4	Public Health	1	1	38
5	Social Sciences	1	1	38

Michael Makanga

Publications

793

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of artemether–lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria Catherine O. Falade, Michael Makanga, Zul Premji, Transactions of the Royal Society of Tropical Medicine and Hygiene African InfantsTranslational MedicineUncomplicated Falciparum MalariaAfrican ChildrenRapid Parasite Clearance	2005	160
EFFICACY AND SAFETY OF THE SIX-DOSE REGIMEN OF ARTEMETHER-LUMEFANTRINE IN PEDIATRICS WITH UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA Michael Makanga, Zul Premji, Catherine O. Falade, American Journal of Tropical Medicine and Hygiene Patient DataHealth SciencesClinical TherapeuticPediatric HematologyMalaria	2006	82
Scientific impact increases when researchers publish in open access and international collaboration: A bibliometric analysis on poverty-related disease papers J. Gabrielle Breugelmans, Guillaume Roberge, Chantale Tippett, PLoS ONE	2018	79
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis Steven E. Kern, Alfred B. Tiono, Michael Makanga, Malaria Journal	2011	74
Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Bernhards Ogutu, Alfred B. Tiono, Michael Makanga, Malaria Journal	2010	59
Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis Michael Makanga, Quique Bassat, Catherine O. Falade, American Journal of Tropical Medicine and Hygiene	2011	53
Strengthening national health research systems in the WHO African Region – progress towards universal health coverage Simbarashe Rusakaniko, Michael Makanga, Martin O. C. Ota, Globalization and Health	2019	50
Towards a proteomic definition of CoArtem action in <b><i>Plasmodium falciparum</i></b> malaria Michael Makanga, Patrick G. Bray, Paul Horrocks, PROTEOMICS	2005	43
Bibliometric Assessment of European and Sub-Saharan African Research Output on Poverty-Related and Neglected Infectious Diseases from 2003 to 2011 J. Gabrielle Breugelmans, Michael Makanga, Ana Lúcia V. Cardoso, PLoS neglected tropical diseases	2015	40
Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks Thomas Nyirenda, Moses J. Bockarie, Shingai Machingaidze, International Journal of Infectious Diseases Family MedicineInstitutional CollaborationSocial SciencesHigh-quality Clinical ResearchGlobal Health Program	2021	38

Page 1